WO2002042735A3 - Human kcr1 regulation of herg potassium channel block - Google Patents
Human kcr1 regulation of herg potassium channel block Download PDFInfo
- Publication number
- WO2002042735A3 WO2002042735A3 PCT/US2001/045644 US0145644W WO0242735A3 WO 2002042735 A3 WO2002042735 A3 WO 2002042735A3 US 0145644 W US0145644 W US 0145644W WO 0242735 A3 WO0242735 A3 WO 0242735A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- kcr1
- potassium channel
- methods
- regulation
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002241555A AU2002241555A1 (en) | 2000-10-30 | 2001-10-30 | Human kcr1 regulation of herg potassium channel block |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24434000P | 2000-10-30 | 2000-10-30 | |
US60/244,340 | 2000-10-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2002042735A2 WO2002042735A2 (en) | 2002-05-30 |
WO2002042735A9 WO2002042735A9 (en) | 2003-02-06 |
WO2002042735A3 true WO2002042735A3 (en) | 2004-05-06 |
Family
ID=22922326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/045644 WO2002042735A2 (en) | 2000-10-30 | 2001-10-30 | Human kcr1 regulation of herg potassium channel block |
Country Status (3)
Country | Link |
---|---|
US (1) | US20030013136A1 (en) |
AU (1) | AU2002241555A1 (en) |
WO (1) | WO2002042735A2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1440256A (en) * | 2000-05-08 | 2003-09-03 | 布雷恩斯盖特有限公司 | Method and apparatus for stimulating sphenopalatine ganglion to modify properties of BBB and cerebral blood flow |
US7146209B2 (en) * | 2000-05-08 | 2006-12-05 | Brainsgate, Ltd. | Stimulation for treating eye pathologies |
US7117033B2 (en) * | 2000-05-08 | 2006-10-03 | Brainsgate, Ltd. | Stimulation for acute conditions |
US6783979B2 (en) * | 2001-06-06 | 2004-08-31 | The Trustees Of Columbia University In The City Of New York Research Foundation Of State University Of New York | Vectors encoding HCN channels and MiRP1 |
WO2002098287A2 (en) * | 2001-06-06 | 2002-12-12 | The Trustees Of Columbia University In The City Of New York | A high throughput biological heart rate monitor that is molecularly determined |
IL159819A0 (en) * | 2001-07-13 | 2004-06-20 | Janssen Pharmaceutica Nv | Cardiovascular safety assay |
KR20050000409A (en) * | 2002-04-25 | 2005-01-03 | 브레인스게이트 리미티드 | Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head |
US7684859B2 (en) * | 2002-04-25 | 2010-03-23 | Brainsgate Ltd. | Stimulation of the OTIC ganglion for treating medical conditions |
US7561919B2 (en) * | 2002-11-14 | 2009-07-14 | Brainsgate Ltd. | SPG stimulation via the greater palatine canal |
JP2006515999A (en) * | 2002-11-14 | 2006-06-15 | ブレインズゲート リミティド | Surgical tools and techniques for stimulation |
ATE415959T1 (en) * | 2003-09-04 | 2008-12-15 | Neurosearch As | HERG1 CHANNEL OPENER FOR THE TREATMENT OF HEART ARRYTHMIA |
US8055347B2 (en) | 2005-08-19 | 2011-11-08 | Brainsgate Ltd. | Stimulation for treating brain events and other conditions |
US8010189B2 (en) | 2004-02-20 | 2011-08-30 | Brainsgate Ltd. | SPG stimulation for treating complications of subarachnoid hemorrhage |
US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
US20090299418A1 (en) * | 2004-08-23 | 2009-12-03 | Brainsgate Ltd. | Concurrent bilateral spg modulation |
AU2005316270A1 (en) * | 2004-12-16 | 2006-06-22 | Novascreen Biosciences | A method for identification and functional characterization of agents which modulate ion channel activity |
US7396524B2 (en) * | 2005-08-02 | 2008-07-08 | Main Line Health Heart Center | Methods for screening compounds for proarrhythmic risk and antiarrhythmic efficacy |
US20090210026A1 (en) * | 2006-08-17 | 2009-08-20 | Brainsgate Ltd. | Spg stimulation for enhancing neurogenesis and brain metabolism |
US7860569B2 (en) | 2007-10-18 | 2010-12-28 | Brainsgate, Ltd. | Long-term SPG stimulation therapy for prevention of vascular dementia |
EP2878335B1 (en) | 2013-11-10 | 2018-01-03 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
EP3093043B1 (en) | 2015-05-13 | 2018-11-14 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
-
2001
- 2001-10-30 AU AU2002241555A patent/AU2002241555A1/en not_active Abandoned
- 2001-10-30 WO PCT/US2001/045644 patent/WO2002042735A2/en active Search and Examination
- 2001-10-30 US US10/000,151 patent/US20030013136A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
SANGUINETTI M.C. ET AL.: "Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia", PROC. NATL. ACAD. SCI. USA, vol. 93, March 1996 (1996-03-01), pages 2208 - 2212, XP002974220 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002241555A1 (en) | 2002-06-03 |
US20030013136A1 (en) | 2003-01-16 |
WO2002042735A9 (en) | 2003-02-06 |
WO2002042735A2 (en) | 2002-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002042735A3 (en) | Human kcr1 regulation of herg potassium channel block | |
FR2736829B1 (en) | COMPOSITION FOR FIGHTING AGAINST SPOTS AND / OR AGING OF THE SKIN, USES THEREOF | |
FR2781666B1 (en) | SOLID COSMETIC COMPOSITION AND USES THEREOF | |
BR9609908A (en) | Pyridazin derivatives - 3 - on its use and intermediates for its production | |
DE59710621D1 (en) | Gap sealing device | |
AU2002309827A1 (en) | Purchase selection behavior analysis system and method | |
AU2003265859A1 (en) | Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents | |
NO983240L (en) | Procedure for the analysis of corrosion and for the prevention of corrosion | |
AU2001286458A1 (en) | Computer program and method for determining the economic impact of long-term care | |
IT1305624B1 (en) | FOOTWEAR ITEM AND METHOD FOR ITS MANUFACTURE | |
FR2733148B1 (en) | COMPOSITION FOR FIGHTING AGAINST SPOTS AND / OR AGING OF THE SKIN, USES THEREOF | |
ITTO940549A0 (en) | GRINDING TOOL AND METHOD FOR ITS MANUFACTURE. | |
DK0840548T3 (en) | Synergistic, herbicidal composition and method of preparation thereof | |
IT1289883B1 (en) | ANTI-TUBERCULAR PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PRODUCTION | |
IT1289819B1 (en) | GRINDER TOOL AND METHOD FOR ITS MANUFACTURE. | |
IT1294006B1 (en) | CEILING AND PROCEDURE FOR ITS CONSTRUCTION | |
HK1054847A1 (en) | Materials and products using strip of real or artificial fur. | |
HUP0102850A2 (en) | Methods and compositions for the determination of protein function and identification of modulators thereof | |
DE69417869D1 (en) | Split nail | |
IT1295339B1 (en) | NON-COMBUSTIBLE COATING AND PROCEDURE FOR ITS MANUFACTURE | |
DE29811618U1 (en) | Crown and bridge framework | |
AU7768298A (en) | Method for capturing, analyzing and representing the movement of bodies and objects | |
ITRM930002A0 (en) | ANTIBIOGRAM AND DIAGNOSTIC KIT FOR ITS CREATION. | |
DE29707372U1 (en) | Device for fastening and sealing ridge and / or ridge tiles | |
ATA96593A (en) | BONE NAIL |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 1/15-15/15, DRAWINGS, REPLACED BY NEW PAGES 1/9-9/9; DUE TO LATE TRANSMITTAL BY THE RECEIVINGOFFICE |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: JP |